Gliomas are the most common and malignant intracranial tumors in adults. Recent studies
have revealed the significance of functional genomics for glioma pathophysiological studies …

Gliomas are the most common malignant tumors of the brain. Immune checkpoints have
been increasingly emphasized as targets for treating malignant tumors. B7‐H3 has been …

Background: PD-L1 has been widely reported as immune check points in a range of
malignancies as well as some immune-originated diseases. In glioma, the role of PD-L1 remains …

Recurrence and progression to higher grade lesions are key biological events and
characteristic behaviors in the evolution process of glioma. Malignant astrocytic tumors such as …

Background: Researches on immunotherapy of glioma has been increasing exponentially
in recent years. However, autoimmune-like side effects of current immune checkpoint …

To follow the revision of the fourth edition of WHO classification and the recent progress on
the management of diffuse gliomas, the joint guideline committee of Chinese Glioma …

Purpose: Glioma tissues consist of not only glioma cells but also glioma-associated nontumor
cells, such as stromal cells and immune cells. These nontumor cells dilute the purity of …

Preoperative MRI is one of the most important clinical results for the diagnosis and treatment
of glioma patients. The objective of this study was to construct a stable and validatable …

Glioma is a fatal brain tumor characterized by rapid proliferation and treatment resistance.
Ferroptosis is a newly discovered programmed cell death and plays a crucial role in the …

The cancer immunotherapy field has rapidly grown in the past few years, largely driven by
the success of immune checkpoint blockade. However, the immunotherapies for solid tumors …